Chris Moose

The clock is ticking on pharma’s digital transformation. As patient expectations rise and competitors invest in virtual care, telehealth has shifted from an emerging trend to a necessity. This session will explore the consequences of inaction, highlighting how digital-first competitors and direct-to-consumer models are reshaping access to care. As new players redefine the patient journey, pharma companies that fail to adapt risk losing influence and market share. Join us to uncover how telehealth is reshaping patient access, trust, and engagement—and why embracing it now is critical to staying competitive. This workshop will explore actionable strategies for integrating telehealth into your commercial model, mitigating risks, and positioning your brand at the forefront of healthcare innovation. 

What you’ll learn: 

• How telehealth eliminates barriers to care and expands patient access 

• Strategies for embedding telehealth into pharma’s patient engagement models 

• Real-world examples of pharma-led telehealth programs delivering measurable outcomes 

• The key steps to ensure your digital transformation aligns with industry innovation